Anti-HMGB1 pAb-treated septic mice had a survival advantage compared to control mice following secondary infection and treatment was associated with improved antimicrobial responses as mice exhibited increased IL-12 and decreased IL-6 following infection. This evidence concerns the gene HMGB1 and infection.